
Oncology NEWS International
- Oncology NEWS International Vol 7 No 7
- Volume 7
- Issue 7
Exhibit Explores Healing Power of Creating Artwork
LOS ANGELES--An exhibit featuring works by five women artists who have lived with cancer was displayed in conjunction with the 1998 Oncology Nursing Society and ASCO meetings.
LOS ANGELES--An exhibit featuring works by five women artists who have lived with cancer was displayed in conjunction with the 1998 Oncology Nursing Society and ASCO meetings.
Novartis Oncology sponsored the exhibit, entitled Medicine Cures the Body, Art Heals the Spirit, along with The Creative Center for Women With Cancer, a New York-based nonprofit organization founded on a belief in the healing power of creative activity. The exhibit is part of Novartis Living With Cancer initiative, which provides support to cancer patients, their families, and friends.
The artists include Lise Poirier (Figure1); photographer Susan B. Markisz; Robin Glazer, art director for The Creative Center; Susan Shatter, whose work is on display at the Art Institute of Chicago and other museums; and sculptor Leonda Finke (Figure 2).
Articles in this issue
almost 28 years ago
Calling the National Cancer Institutealmost 28 years ago
Six Cycles of AT Found Safe in Advanced Breast Canceralmost 28 years ago
New Drug Promising in Advanced Pancreatic Canceralmost 28 years ago
Herceptin/Chemo Effective in Metastatic Breast Canceralmost 28 years ago
Virtual Reality Exhibit Simulates Cancer Fatiguealmost 28 years ago
New Director of AIDS Researchalmost 28 years ago
Update on Trials of Thrombopoietin for Platelet Recoveryalmost 28 years ago
Amifostine Reduces Xerostomia After RT for Head and Neck Canceralmost 28 years ago
National Survey Documents Gap in Quality of HIV/AIDS CareNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content


138 HER2CLIMB-05: A Randomized, Double-blind, Phase 3 Study of Tucatinib Versus Placebo Added to Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer

















































